| Literature DB >> 25885344 |
Cristian A Alvarez Rojas1, Brendan R E Ansell2, Ross S Hall3, Robin B Gasser4, Neil D Young5, Aaron R Jex6, Jean-Pierre Y Scheerlinck7.
Abstract
BACKGROUND: Although fascioliasis has been relatively well studied, little is known about the molecular basis of this disease. This is particularly relevant, considering the very different response that sheep have to Fasciola hepatica relative to cattle. The acute phase of this disease is severe in sheep, whereas chronic fascioliasis is more common in cattle.Entities:
Mesh:
Year: 2015 PMID: 25885344 PMCID: PMC4382932 DOI: 10.1186/s13071-015-0715-7
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Figure 1Eosinophil count in blood and histological sections of liver tissue from infected and control sheep. (A) Eosinophil count (% of total white blood cells) after microscopic examination of peripheral blood smears from the infected (INF-1, INF-2, INF-3 and INF-4) and control (CON-1, CON-2, CON-3 and CON-4) sheep. Normal range for eosinophils in sheep: 1-10%. (B) Average of eosinophil count from 10 fields at 400X in histology sections of each biological replicate from the infected and control groups. (C) Typical microscopic appearance (400X) of liver from the infected sheep at 8 weeks post infection, massive infiltration of inflammatory cells and deposition of collagen can be observed. (D) Normal architecture of the liver from control animals.
Overrepresented Gene ontology (GO) terms for up- (↑) and down- regulated (↓) genes in infected liver
|
|
|
|
|---|---|---|
|
| ||
| cholesterol 7-alpha-monooxygenase activity (GO:0008123) | ↓ | 0.0017 |
| flavin-containing monooxygenase activity (GO:0004499) | ↓ | 0.0086 |
| leukotriene-B4 20-monooxygenase activity (GO:0050051) | ↓ | 0.0069 |
| arachidonic acid 11 12-epoxygenase activity (GO:0008405) | ↓ | 0.0017 |
| arachidonic acid 14 15-epoxygenase activity (GO:0008404) | ↓ | 0.0017 |
| alkane 1-monooxygenase activity (GO:0018685) | ↓ | 0.0086 |
| linoleic acid epoxygenase activity (GO:0071614) | ↓ | 0.0017 |
|
| ||
| neutrophil aggregation (GO:0070488) | ↑ | 0.0007 |
| neutrophil chemotaxis (GO:0030593) | ↑ | 0.0004 |
| regulation of T-helper 2 cell differentiation (GO:0045628) | ↑ | 0.0015 |
| regulation of B cell activation (GO:0050864) | ↑ | 0.0007 |
| negative regulation of B cell apoptosis (GO:0002903) | ↑ | 0.0015 |
| cellular response to type I interferon (GO:0071357) | ↓ | 0.0017 |
| positive regulation of interferon-alpha production (GO:0032727) | ↓ | 0.0001 |
| positive regulation of interferon-beta production (GO:0032728) | ↓ | 0.0006 |
| regulation of type III interferon production (GO:0034344) | ↓ | 0.00001 |
|
| ||
| collagen type I (GO:0005584) | ↑ | 0.0007 |
| proteinaceous extracellular matrix (GO:0005578) | ↑ | 0.0002 |
| extracellular matrix (GO:0031012) | ↑ | 0.0007 |
*p-value < 0.05.
Analysis revealed GO terms related with oxidoreductase (‘molecular function’), immune system (‘biological processes’) and extra cellular matrix (‘cellular component’).
Full list of GO analyses can be seen in Additional file 3.
Enriched KEGG pathways for up- (↑) and down-regulated (↓) genes in infected liver parenchyma
|
|
|
|
|
|---|---|---|---|
|
| |||
| Jak-STAT signalling pathway (ko04630) | STAT1, GHR | ↓ | 0.004 |
| TNF signalling pathway (ko04668) | RPS6KA5 | ↓ | 0.021 |
| NF-kappa B signalling pathway (ko04064) | DDX58 | ↓ | 0.025 |
| NF-kappa B signalling pathway (ko04064) | LAT, CCL4, RELB, TNF, TNFSF14, TLR4, IGLL1, TICAM1 | ↑ | 0.009 |
| PI3K-Akt signalling pathway (ko04151) | GHR, C-MET | ↓ | 0.039 |
|
| |||
| Cytokine-cytokine receptor (ko04060) | TNFSF10, GHR, C-MET | ↓ | 0.001 |
| Cytokine-cytokine receptor (ko04060) | CXCR2, ACKR3, INHBA, CCL4, IL1R2, TNF, TNFSF12, CCL3, TGFB1, PF4, TNFSF14, CSF3R | ↑ | 0.027 |
| ECM-receptor interaction (ko04512) | OST, COL1A2, THBS2, VWF, COL6A3, HMMR, COL1A1 | ↑ | 0.007 |
*p-value < 0.05.
Analysis revealed KEGG pathways related with signal transduction and signalling molecules and interaction.
Full list of KEGG pathways analyses can be seen in Additional file 4.
Summary of KEGG Brite ontology analysis for up- (↑) and down- regulated (↓) genes in infected liver
|
|
|
|
|
|---|---|---|---|
| Cytochrome P450 | ko00199 | ↓ | 0.00001 |
| Cytokine receptors | ko04050 | ↓ | 0.0041 |
| Enzyme-linked receptors | ko01020 | ↓ | 0.0082 |
| Cellular antigens | ko04090 | ↓ | 0.0492 |
| Chromosome | ko03036 | ↑ | 0.00000001 |
| DNA repair and recombination proteins | ko03400 | ↑ | 0.00003 |
| DNA replication proteins | ko03032 | ↑ | 0.00018 |
| Cellular antigens | ko04090 | ↑ | 0.00036 |
| Cytoskeleton proteins | ko04812 | ↑ | 0.00064 |
| Exosome | ko04147 | ↑ | 0.0074 |
| Cytokines | ko04052 | ↑ | 0.0088 |
| Enzymes | ko01000 | ↑ | 0.023 |
| Lectins | ko04091 | ↑ | 0.034 |
| Cell adhesion molecules and their ligands | ko04516 | ↑ | 0.037 |
| Heparan sulphate/heparin binding proteins | ko00536 | ↑ | 0.045 |
*p-value < 0.05.
Figure 2Change in transcription of genes involved in Th1/Th17 and Th2 immune responses. Legend: Names on vertical axis represent proteins encoded by these genes. Fold-change on the horizontal axis was calculated using averaged TPM values for infected and control groups of sheep. TLR4: Toll-like receptor 4, CD86: CD86 antigen, TNFα: tumour necrosis factor alpha, BCL6: B-cell CLL/lymphoma 6, TGF-β1: transforming growth factor-beta 1 and IL27Rα: interleukin 27 receptor, alpha.
Figure 3Change in transcription of genes involved in hepatotoxicity (blue bars), fibrosis (orange) and extracellular matrix formation (ECM) (red). Legend: Names on vertical axis represent proteins encoded by these genes. Coloured bars indicate the fold change between TPM values for infected compared with control sheep. Fold-change on the horizontal axis was calculated using averaged TPM values for infected and control groups. TGLN: transgelin, SLC2A3: solute carrier family 2 member 3, TIMP1: tissue inhibitor of metalloproteinases 1, TGF-β1: transforming growth factor beta 1, TNF: tumour necrosis factor, COL1A1: collagen, type I, alpha 1, OST: osteopontin and COL16A1: collagen, type I, alpha 1: collagen, type XVI, alpha 1.